Ethnicity and Risk for Colorectal Cancers Showing Somatic BRAF V600E Mutation or CpG Island Methylator Phenotype
about
CpG island methylation in colorectal cancer: past, present and futureMolecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldLifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiologySerrated polyposis: an enigmatic model of colorectal cancer predispositionSerrated lesions of the colorectum: review and recommendations from an expert panelBRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis.Serrated polyps and their alternative pathway to the colorectal cancer: a systematic reviewColorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular featuresEpidemiology of goblet cell and microvesicular hyperplastic polyps.Lessons from Lynch syndrome: a tumor biology-based approach to familial colorectal cancer.Findings in young adults at colonoscopy from a hospital service database auditPTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.The clinical significance of serrated polyps.BRAF mutation is associated with poor clinicopathological outcomes in colorectal cancer: A meta-analysis.Smoking, gender, and ethnicity predict somatic BRAF mutations in colorectal cancer.A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma.Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical managementCpG island methylator phenotype and prognosis of colorectal cancer in Northeast China.Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancerPIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival.Germline Mutations in the Polyposis-Associated Genes BMPR1A, SMAD4, PTEN, MUTYH and GREM1 Are Not Common in Individuals with Serrated Polyposis Syndrome.Colorectal cancers from distinct ancestral populations show variations in BRAF mutation frequencyContext-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer.Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family historyPredictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803Tracking the Correlation Between CpG Island Methylator Phenotype and Other Molecular Features and Clinicopathological Features in Human Colorectal Cancers: A Systematic Review and Meta-Analysis.No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections.BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics.The role of EGFR monoclonal antibodies (MoABs) cetuximab/panitumab, and BRAF inhibitors in BRAF mutated colorectal cancer.Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis.Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas.p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosisVitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer.Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis.A cohort study of p27 localization in colon cancer, body mass index, and patient survival.Molecular characteristics of mismatch repair genes in sporadic colorectal tumors in Czech patientsNovel prognostic biomarkers in colorectal cancer.Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis.Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS- but not BRAF+ colorectal cancer.
P2860
Q24597977-46B28D3E-4EF5-4C6F-AE8A-BF15F3150D76Q24620628-8033A213-4CEB-457D-A1B9-19FE20CDDC84Q24622814-AFF38701-B2EF-4D38-9E4A-FBF8B2D3296EQ24623224-DC42B428-4A5B-407C-A4F8-70ED828E5E64Q26827208-6CCA9AC2-2E62-4BB3-9460-0FA55BADE473Q27852942-DDF18A1F-7B6F-4651-821B-92AAA44FE0AFQ28081212-16ADD3B7-357C-48A7-B0DF-73CD1FB0010AQ28284149-38C79C4F-7F25-4885-B6A7-7424678AF412Q30487382-C8680467-C31F-4482-A74B-EFAB4B51E8E7Q33550512-D7FE9E4E-5FCC-4BEC-8EA0-C5168697A418Q33576415-B485CAD7-B3BD-415B-B077-65B7963426B6Q33723499-6FAC2092-D555-4283-BAF2-ED051568BD8DQ33736606-B2B1269F-AA9C-4C70-90A2-1A4421391D9DQ33796513-B462C84A-6363-420D-A275-B05038FF01DEQ33857897-6C2A0611-1835-4DBF-9407-1BB50E182FD2Q33945376-EF61AE81-29D6-435B-AEDD-C295ED96F036Q34034620-E1992ECD-1AAE-4244-9901-490F4767A714Q34177058-833CE807-B2B7-4498-8D51-10EC1ABE02A2Q34358286-FC394595-E90A-4253-9E53-215F1231CB63Q34778710-FC741585-C249-4F56-AFD4-8FB427C41BAEQ34785531-82243C2A-59D5-4CC0-A060-99AC6650F398Q34997425-2BC32001-F429-4F3C-9708-30B60E878324Q35001203-5EF56655-9BBA-413C-A319-15458DADA446Q35045711-669DF1FD-6CA3-4F3D-A11C-7DB9789A2974Q35163670-E38AABBF-46EE-466B-BE02-226D42E713A9Q35729861-660E236B-65BB-4650-92BF-0CFF4D12535FQ35952149-A98E53EF-3F91-40F3-8539-509E686ECAA2Q36059870-0F58D589-6C48-473C-8245-78E7A1CA80CBQ36306276-9721ECE3-A988-4B9F-B638-03156E62B747Q36582552-35A36306-5290-44E5-9165-D6CF83EF4725Q36594927-6534B760-9AC2-404F-B1B4-62F894BAAEF0Q37274510-0A4D99EA-D67C-4DD9-BA9D-A8B9F1AE6EC2Q37379089-C94C3031-A292-4D96-AD98-038676C78C63Q37400664-65DB1BEB-D5CF-4E84-8931-A04EF8B7B7BDQ37400731-2386559C-ABC2-46EE-A69B-C06C9F9FE97DQ37403698-B919B950-7C85-4205-B089-06B57810CC69Q37554315-03DB7008-96E0-429C-9295-E77581BF730BQ38020732-87EE78F4-B5E4-4199-A3CA-55C4D4E2E927Q38403904-0EDD88B5-F867-4C47-BF7B-FC32213FCBA7Q39102623-B5B1C7BF-36A9-482B-94BF-FFFF113A1980
P2860
Ethnicity and Risk for Colorectal Cancers Showing Somatic BRAF V600E Mutation or CpG Island Methylator Phenotype
description
article
@en
im Juli 2008 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2008
@uk
name
Ethnicity and Risk for Colorec ...... pG Island Methylator Phenotype
@en
Ethnicity and Risk for Colorec ...... pG Island Methylator Phenotype
@nl
type
label
Ethnicity and Risk for Colorec ...... pG Island Methylator Phenotype
@en
Ethnicity and Risk for Colorec ...... pG Island Methylator Phenotype
@nl
prefLabel
Ethnicity and Risk for Colorec ...... pG Island Methylator Phenotype
@en
Ethnicity and Risk for Colorec ...... pG Island Methylator Phenotype
@nl
P2093
P50
P1476
Ethnicity and risk for colorec ...... pG island methylator phenotype
@en
P2093
Andrew M Haydon
Jeremy J Jass
John L Hopper
Melissa A Barker
Michael D Walsh
Simon G Royce
Susan Parry
P304
P356
10.1158/1055-9965.EPI-08-0091
P50
P577
2008-07-01T00:00:00Z